Tradestie Institutional Equity Comparison Engine

OVID vs PYPD โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-17 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

PYPD Overall Edge

PYPD Captures Institutional Edge (3โ€“1 Pillars ยท 4โ€“5 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to PolyPid Ltd. Ordinary Shares (PYPD) driven by superior Growth & Margin, Momentum & Technical, Options & Structure while OVID counters with relative strength in Valuation. Fundamentally, OVID trades at 1.8x Forward P/E with -4693.7% operating margin (-88.3% YoY revenue) versus PYPD at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, OVID sits in CONSOLIDATION (30th %ile IV; Dealer Gamma Walls on Pro) against PYPD sits in BREAKOUT (12th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner OVID
OVID 1.8x vs PYPD N/M Fwd P/E
Growth & Margin Winner PYPD
Op Margin -4693.7% vs 0.0% ยท YoY -88.3% vs +0.0%
Momentum & Technical Winner PYPD
1Y +68.2% vs +81.0% ยท 52W Pos 53% vs 82%
Options & Structure Winner PYPD
CONSOLIDATION (30th %ile IV) vs BREAKOUT (12th %ile IV)
OVID NASDAQ
Ovid Therapeutics Inc. Common Stock
Pharmaceutical Preparations
$2.19
-8.54% 1D
Market Cap $479.4M
1M Return +1.15%
1Y Return +68.2%
Forward P/E 1.8x
Unified AI Score
52.3 / 100 HOLD
Tech 29.0 Fund 48.0 Flow 68.0 Mom 50.0
PYPD NASDAQ
PolyPid Ltd. Ordinary Shares
Surgical & Medical Instruments & Apparatus
$6.50
+5.63% 1D
Market Cap $132.2M
1M Return +33.12%
1Y Return +80.95%
Forward P/E N/M
Unified AI Score
31.1 / 100 SELL
Tech 50.0 Fund 27.0 Flow 56.0 Mom 32.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: OVID +68.2% PYPD +80.95% Spread: +12.75 pp (PYPD Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
OVID TTM Op. Margin: -4693.7% PYPD TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on OVID vs PYPD. Trailing 12-month operating profitability (OVID -4693.7% vs PYPD 0.0%) and valuation multiples (OVID 1.8x vs PYPD N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: OVID (5) vs PYPD (4)
Institutional Metric OVID PYPD Criterion Row Winner
Market Capitalization Scale $479.4M $132.2M Larger Scale OVID
Trailing P/E Ratio Valuation 1.8x N/M Lower Multiple OVID
Forward P/E Ratio Valuation 1.8x N/M Lower Multiple OVID
Revenue Growth (YoY) Growth -88.3% +0.0% Higher Growth PYPD
Operating Margin (TTM) Profitability -4693.7% 0.0% Higher Margin PYPD
Net Profit Margin Profitability 0.0% 0.0% Higher Margin Tie
Return on Equity (ROE) Capital Efficiency -35.4% -243.6% Higher ROE OVID
52-Week Range Position Momentum 53% ($1โ€“$3) 82% ($4โ€“$7) Stronger Trend PYPD
Beta / 30D Volatility Risk Regime 1.06ฮฒ ยท 99% Vol 0.88ฮฒ ยท 59% Vol Lower Realized Risk PYPD
Unified Institutional Score Composite Signal 52.3 / 100 (HOLD) 31.1 / 100 (SELL) Higher Composite OVID

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full OVID vs PYPD Buy Guide
OVID CONSOLIDATION
151d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 30th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live OVID Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
PYPD BREAKOUT
40d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 12th %ile
IV Regime Compressed (<25th %ile)
Live PYPD Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither OVID nor PYPD registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.